What's in Kite, A Gilead Company's pipeline?

Kite, A Gilead Company has 7 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 4 in Phase 2, 1 in Phase 1.

Which companies overlap with Kite, A Gilead Company's portfolio?

Top competitors by shared drug class: Celgene, Amgen, Beijing Yongtai Ruike Biotechnology Company Ltd, Biocad, Cancer Trials Ireland.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kite-a-gilead-company.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Kite, A Gilead Company — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kite, A Gilead Company pipeline: 0 marketed, 0 filed, 2 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 4 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
KITE-753	KITE-753	phase 3	CAR-T cell therapy	Tumor-associated antigen (specific target not publicly disclosed in detail)	Oncology
Platinum-containing Salvage Chemotherapy	Platinum-containing Salvage Chemotherapy	phase 3	Platinum-based chemotherapy agent	DNA	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Celgene · 3 shared drug classes
Amgen · 1 shared drug class
Beijing Yongtai Ruike Biotechnology Company Ltd · 1 shared drug class
Biocad · 1 shared drug class
Cancer Trials Ireland · 1 shared drug class
Allife Medical Science and Technology Co., Ltd. · 1 shared drug class
Celyad Oncology SA · 1 shared drug class
Akeso · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kite, A Gilead Company:

Cite this brief

Drug Landscape (2026). Kite, A Gilead Company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kite-a-gilead-company. Accessed 2026-05-18.